INDUSTRY PARTNERS

Thank you to the following companies for their continued support of the New Zealand Branch Meeting.

Gold Partner 

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology; BioPharmaceuticals; Vaccine and Immune Therapies; and Rare Disease. We collaborate with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia-New Zealand, we have been working to deliver the best value to patients for more than 60 years, and we push the boundaries of science to deliver life-changing medicines. AstraZeneca is harnessing the power of science and innovation and our global reach to build a healthy future for people, society, and the planet.

Bronze Partner 

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology; BioPharmaceuticals; Vaccine and Immune Therapies; and Rare Disease. We collaborate with world-renowned scientists and academic institutions, and partner with like-minded, science-led companies. At AstraZeneca Australia-New Zealand, we have been working to deliver the best value to patients for more than 60 years, and we push the boundaries of science to deliver life-changing medicines. AstraZeneca is harnessing the power of science and innovation and our global reach to build a healthy future for people, society, and the planet.

The Organising Committee welcomes all enquiries from industry partners for sponsorship and exhibition investment at the New Zealand Branch Meeting. Please contact our Conference Managers to review investment opportunities or for further information.